Document is current
Any future updates will be listed below
-
Authors
Duan, Ruixue
Li, Zhitong
Li, Xuhui
Ren, Wenxia
Li, Jiaojiao
Bai, Yajing
Lü, Angxian
Yan, Yuanyuan
Zhao, Anqi
Liu, Shiwei
-
Funding
Funding for this research was provided by:
Shanxi Province Basic Research Program (202303021212330)
Collaborative Traditional Chinese and Modern Medicine for Chronic Disease Management Research Project (CXZH2024085)
Shanxi Province Metabolic Disease (Type 1 Diabetes) Clinical Medical Research Center (20240410501001)
Shanxi Province Science and Technology Achievements Transformation Guidance Special Fund (202304021301066)
Shanxi Province Science and Technology Innovation Talent Team Special Plan (202204051002029)
Shanxi Province Research Funding for Returned Overseas Scholars (2024-143)
Shanxi Province Key Laboratory of Endocrine and Metabolic Diseases (202404010920011)
- License Information
-
More Information
Article History
Received: 27 August 2025
Accepted: 26 December 2025
First Online: 6 January 2026
Declarations
:
: Approval for this project was granted by the Biomedical Ethics Committee of Peking University (Beijing, China) (IRB00001052-11015), with our study adhering strictly to the principles outlined in the Declaration of Helsinki, and obtaining informed consent from all participants.
: Not applicable.
: The authors declare no competing interests.
